Living with plaque psoriasis can affect more than just your skin. Join plaque psoriasis and obesity clinical trials focused on expanding research and improving understanding of these conditions. Your participation can support the development of future care approaches for individuals managing both psoriasis and obesity.
Finding It Difficult to Manage Plaque Psoriasis and Weight Challenges? Connect with MetroBoston
Overweight Plaque Psoriasis Study in Boston
Around 3% of the world’s population is affected by plaque psoriasis, a chronic autoimmune skin condition that causes rapid skin cell buildup, resulting in thick, red, inflamed patches that may cause itching and discomfort. In adults living with both plaque psoriasis and obesity or overweight, symptoms can be more persistent and harder to manage, impacting daily life and overall well-being.
At MetroBoston, we are conducting a research study in adults with moderate-to-severe plaque psoriasis and obesity or overweight with at least one weight-related health condition. The study takes place in a routine clinical care setting and looks at how an investigational therapy performs when added to an existing treatment. The goal is to better understand how these two conditions may be addressed together under regular medical supervision.
Enroll Now
Enroll in Obesity and Plaque Psoriasis Clinical Research
Participation Criteria:
If you are eligible, enroll in plaque psoriasis clinical trials in Boston and contribute to ongoing research aimed at improving understanding of plaque psoriasis in individuals living with obesity or overweight. Participation is voluntary.
Age Group
18 Years and Older
Gender
Both
Current Status
Recruiting
Total Studies
01
Location
Boston
Frequently Asked Questions
What is the plaque psoriasis and obesity research study about?
The research study is looking at how an investigational therapy performs in adults living with moderate-to-severe plaque psoriasis and obesity to better understand how these two conditions may be addressed together under regular medical supervision.
Who may be eligible to participate in this plaque psoriasis clinical trial?
Adults aged 18 and older with moderate-to-severe plaque psoriasis and a BMI of 30 or above (obesity), or a BMI between 27 and 30 (overweight) with at least one weight-related health condition, such as high blood pressure, type 2 diabetes, sleep apnea, or cardiovascular disease — may be eligible.
What is involved in participating in this obesity and plaque psoriasis clinical research?
Participation involves routine clinic visits at 6 and 12 months as part of your regular care. During these visits, the study team will collect information related to your skin condition and weight.
Is this a plaque psoriasis clinical trial in overweight adults only?
The study includes adults who are either obese (BMI 30 or above) or overweight (BMI between 27 and 30) and have at least one weight-related health condition alongside moderate-to-severe plaque psoriasis. Participation is voluntary.
What is the investigational therapy being studied in this plaque psoriasis and obesity clinical trial?
The study involves an investigational therapy used as an add-on to an existing treatment for plaque psoriasis.
617-789-5300